Collectively, these data indicated that, in Mc4r-KO mice — a model of hyperphagic obesity without leptin deficiency in which hepatic DNL is increased to a lesser extent than in ob/ob mice — hepatic FASN deficiency ameliorated both NAFLD and diabetes. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.